azminah azminah

Dr. azminah azminah

University of Surabaya, Indonesia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
RRRatih Ratih
Ratih Ratih
HWHermann Wätzig
Hermann Wätzig
azminah azminahazminah azminah
azminah azminah
MAMufarreh Asmari
Mufarreh Asmari
BPBenjamin Peters
Benjamin Peters
Sami El DeebSami El Deeb
Sami El Deeb
Chondroitin sulfate A was covalently immobilized onto a monolithic silica epoxy column involving a Schiff base formation in the presence of ethylenediamine as a spacer and evaluated in terms of its selectivity in enantioseparation. The obtained column was utilized as a chiral stationary phase in enantioseparation of amlodipine and verapamil using a mobile phase consisting of 50 mM phosphate buffer pH 3.5 and UV detection. Sample dilution by organic solvents (preferably 25% v/v acetonitrile-aqueous solution) was applied to achieve baseline enantioresolution (Rs > 3.0) of the individual drug models within 7 min, an excellent linearity (R2 = 0.999) and an interday repeatability of 1.1% to 1.8% RSD. The performance of the immobilized column for quantification of racemate in commercial tablets showed a recovery of 86–98% from tablet matrices. Computational modeling by molecular docking was employed to investigate the feasible complexes between enantiomers and the chiral selector.

10 June 2026 in COVID
Verified
Journal Article
Open access
PDF file
HWHeru Wijono
Heru Wijono
FHFauna Herawati
Fauna Herawati
AJAbdul Kadir Jaelani
Abdul Kadir Jaelani
SOStefani Kartika Octavia
Stefani Kartika Octavia
DRDewi Ramdani
Dewi Ramdani
Rika YuliaRika Yulia
Rika Yulia
This study analyses the pharmacological profiles of medications administered to critically ill COVID-19 patients to evaluate their efficacy regarding recovery rates and duration of hospitalization. The results demonstrate a significant difference in clinical outcomes. While the administration of Ceftazidime, Ceftriaxone, and Oseltamivir was associated with negative survival trends, Dexamethasone and Favipiravir were associated with a fourfold higher probability of survival in severe cases. Notably, no pharmacological intervention significantly reduced the length of hospital stay; instead, recovery duration was primarily influenced by comorbidities such as obesity, cardiovascular disease, and diabetes. Furthermore, age and preexisting physiological conditions remained primary predictors of mortality. Observational analysis in our study for drug repurposing identified Amikacin, Remdesivir, and Rivaroxaban as potential therapeutic candidates. However, Dexamethasone was identified as the most effective treatment for recovery, likely due to a molecular structure with high potential binding affinity to the SARS-CoV-2 virus. These findings suggest that while specific repurposed drugs offer measurable benefits, patient history remains a critical determinant of outcomes, highlighting the necessity for further research to refine therapies against emerging viral pathogens.

30 April 2025 in Tropical Journal of Natural Product Research
Verified
Journal Article
Open access
PDF file
MRMarzella D. Rossardy
Marzella D. Rossardy
azminah azminahazminah azminah
azminah azminah
RRRatih Ratih
Ratih Ratih
JSJohan Sukweenadhi
Johan Sukweenadhi
KBKrisyanti Budipramana
Krisyanti Budipramana
Ginsenosides are triterpenoid saponins found in Panax ginseng. They are well known for their health benefits, including antioxidant, anticancer, and antidiabetic effects, along with their support for cardiovascular and neurological function. Our previous study showed that cultivating Panax ginseng in tissue culture successfully led to its rapid growth. Several active compounds, including Rg1 and Re ginsenosides, were identified in the powdered extract of cultivated Panax ginseng. As part of a continuous study, an analytical method was developed to ensure the consistency of yield composition with the required quality standards. The analytical method optimization involved selecting the mobile phase composition and adjusting the flow rate in both isocratic and gradient systems to achieve optimal separation. The gradient elution system, with a constant flow rate of 1.0 mL/min, was more effective than the isocratic system for separating ginsenosides. The optimized method was then validated, showing acceptable validation parameters. The validated method was applied to the ginsenosides assay in the powdered extract of the Panax ginseng sample. Eight out of fourteen ginsenosides were identified, including Rg1 and Re, which were quantified at 0.16% and 0.45%, respectively. A baseline resolution of about 5.16 between Rg1 and Re ginsenosides was achieved. The analytical method developed using HPLC in this study effectively separated ginsenoside compounds simultaneously. These findings proposed an analytical method to evaluate the quality standards of ginsenosides in Panax ginseng.

31 December 2023 in Journal of World Science
Verified
Journal Article
Open access
PDF file
azminah azminahazminah azminah
azminah azminah
MMMunawwarah Munawwarah
Munawwarah Munawwarah
This research aims to deepen our understanding of the effects of nicotine usage through a descriptive literature review, with the primary focus on exploring GEO DataSets via the analysis of Differentially Expressed Genes (DEGs) in response to nicotine exposure. The GEO DataSet search was obtained from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO), a relevant biomedical data source. The results of our investigation revealed a total of 11 GEO DataSets of Homo sapiens that met the inclusion and exclusion criteria for identifying Differentially Expressed Genes (DEGs). These datasets, namely GSE125217, GSE148812, GSE125416, GSE105445, GSE56398, GSE51284, GSE71795, GSE56383, GSE40689, GSE11208, and GSE11142, contained genes that underwent altered expression in response to nicotine exposure. The results of the gene analysis were further categorized based on their functional classifications. They encompass receptor genes such as CHRNA9, nAChRs, and TLR4, regulatory genes including CDK1, CHK1, ERBB2, EGFR, and E2F1, structural genes like H-Caldesmon, L-Caldesmon, SM22, CDH1/3, BDNF/NT-3, and MLL3, immunological genes such as TNF-?, IL-1?, IL-6, IL-10, MCSF, MCP-1, and ICAM-1, metabolic genes like CYP2A6 and APOE, and enzymatic genes such as PITRM1, DDR2, DHRS7, and SLC16A7. This review search provides a comprehensive insight into the molecular-level impact of nicotine, with potential implications for the development of treatment strategies and the discovery of relevant biomarkers associated with nicotine use.